Login

Company update and season’s greetings from Regeneus Dec 2020 - Karolis Rosickas, CEO, Regeneus Ltd 00:00:00

Share On Facebook Share On Twitter

Company update and season’s greetings from Regeneus Dec 2020

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Connecting Education and Industry at the Northern Ontario Mining Showcase
00:10:00
Advancing Space Communication: Optical Laser Technology in Next-Generation Satellite Fleets |Bulent Altan , CEO , Mynaric AG.
00:10:00
Sitowise CEO Heikki Haasmaa Discusses Q2 Growth and Lower-Than-Expected Results | Heikki Haasmaa, CEO, Sitowise Group Oyj.
00:10:00
Barksdale Resources: Unveiling Promising Base Metal Exploration at One-to-One Mining Conference in New York
00:10:00
Discover Sales Opportunities at Agilent: Passion, Innovation, and Customer Focus.
00:10:00
CEO of American Century Investment Manager is interviewed | Jonathan Thomas, CEO, American Century Investment Management, Inc.AS OF 31 JUL 2023
00:10:00
We talk a lot about renewable power, but we also need to build and bring to the market the flexibility components which will complement the energy transition.
00:10:00
Decades of Dedication: Insights from Christopher Tsai on Building PSI Capital | Christopher Tsai, CEO , Tsai Capital.
00:10:00
The power of network effects as the core growth driver of both B2B and B2C successes across every vertical|James Currier,General Partner,NFX
00:10:00
Marco's Insights on the Booming Latino Economy and Investment Strategies
00:10:00
HCVC is an early-stage Venture Capital firm backing hardtech companies worldwide|Alexis Houssou,Managing Partner,HCVC
00:10:00
Interview with Don Bubar, President and CEO of Avalon Advanced Materials, at One-to-One Mining Conference

© 2026 Nehu